Lumicell Pivotal (Breast Cancer) - Clinical Trial
Email to Participate
kimberly.turnage@duke.edu
What is the Purpose of this Study?
We are doing this study to learn better ways to make sure all of the cancer is removed during surgery and to lower the chance that more surgeries will be needed.
What is the Condition Being Studied?
Breast Cancer
Who Can Participate in the Study?
Adults:
- Diagnosed with breast cancer or ductal carcinoma in situ (DCIS)
- Scheduled for a lumpectomy for a breast malignancy.
Age Group
Adults
What is Involved?
If you choose to join this study, you will:
- Get a shot into your vein of the study drug (LUM015) before your surgery
- Have your tumor area scanned with the Lumicell device
Study Details
Full Title
PIVOTAL STUDY OF THE LUM IMAGING SYSTEM FOR ASSISTING INTRAOPERATIVE DETECTION OF RESIDUAL CANCER IN THE TUMOR BED OF FEMALE PATIENTS WITH BREAST CANCER
Principal Investigator
Surgical Oncologist
Protocol Number
IRB:
PRO00102180
NCT:
NCT03686215
Phase
Phase
N/A
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment
Participate